End-of-day quote
Taipei Exchange
07:00:00 2024-03-27 pm EDT
5-day change
1st Jan Change
43.5
TWD
+0.12%
+2.35%
-1.81%
Center Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 11, 2021 at 04:31 pm EDT
Center Laboratories, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 158.377 million compared to TWD 308.636 million a year ago. Operating loss was TWD 319.405 million compared to TWD 5.368 million a year ago. Net income was TWD 2,118.077 million compared to TWD 209.709 million a year ago. Basic earnings per share from continuing operations was TWD 4.63 compared to TWD 0.48 a year ago. Diluted earnings per share from continuing operations was TWD 4.43 compared to TWD 0.47 a year ago.
Center Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 19
CI
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd
Mar. 12
CI
Center Laboratories, Inc. Announces Wang, Su-Chi Holds Concurrent Position as Chief Investment Officer and Chief Operating Officer
Feb. 06
CI
Center Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 10
CI
Center Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-11
CI
Center Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
Center Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-28
CI
Center Laboratories, Inc. Announces Executive Appointments
22-12-08
CI
Center Laboratories, Inc. Announces Management Changes
22-11-30
CI
Center Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-09
CI
Bao Pharma announced that it has received $100 million in funding from Shenzhen Oriental Fortune Capital Co., Ltd., Finnova Capital, Haitong Innovation Private Fund Management Co., Ltd., Shanghai Sun Rock Capital Management Co., Ltd., Center Laboratories, Inc.
22-08-24
CI
Center Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-11
CI
Mycenax Biotech Inc. announced that it expects to receive TWD 1.659112761 billion in funding from JCR Pharmaceuticals Co., Ltd., Center Laboratories, Inc.
22-07-26
CI
TOT BIOPHARM International Company Limited announced that it expects to receive HKD 110 million in funding from Center Laboratories, Inc.
22-05-30
CI
Center Laboratories, Inc. Elects Directors
22-05-20
CI
Center Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-12
CI
Center Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-29
CI
HongKong Jingang Trade Holding Company Limited completed the acquisition of 30.89% stake in Ausnutria Dairy Corporation Ltd from Citagri Easter Ltd, Bioengine Capital Inc., Center Laboratories, Inc. and Bartle van der Meer.
22-01-27
CI
TOT Biopharm Sells 1 Million Shares in Lumosa Therapeutics to Center Laboratories
21-12-08
MT
Center Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-11
CI
HongKong Jingang Trade Holding Company Limited offered to acquire remaining 65.7% stake in Ausnutria Dairy Corporation Ltd from Citagri Easter Ltd, Center Laboratories, Inc. and other group of shareholders for HKD 11.9 billion.
21-10-26
CI
HongKong Jingang Trade Holding Company Limited entered into the Share Purchase Agreement to acquire 30.89% stake in Ausnutria Dairy Corporation Ltd from Citagri Easter Ltd, Bioengine Capital Inc., Center Laboratories, Inc. and Bartle van der Meer for HKD 5.3 billion.
21-10-26
CI
Center Laboratories, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
21-08-12
CI
Center Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
21-05-11
CI
Center Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
21-03-28
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Center Laboratories, Inc. is a Taiwan-based company principally engaged in the production, marketing and distribution of infant nutrition products, as well as the research and development, processing, production, packaging, marketing and sales of dairy products. The Company's main products include dairy products and probiotic products. The Company is also involved in the manufacture, wholesale and retail of western medicines. The Company distributes its products in the domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-1.81% 931M +33.46% 701B +26.24% 571B +0.93% 381B +21.03% 334B +17.51% 319B +0.74% 210B +2.95% 210B -6.05% 201B -3.61% 157B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1